Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Brain : a journal of neurology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/brain/awq337PMID 21233144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis

  2010cited by this paper
• Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5.

  2010cited by this paper
• Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

  2010cited by this paper
• Acid-Sensing Ion Channels in Acidosis-Induced Injury of Human Brain Neurons

  2010cited by this paper
• ASIC2 Subunits Target Acid-Sensing Ion Channels to the Synapse via an Association with PSD-95

  2009cited by this paper
• Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord

  2009cited by this paper
• Sodium channel activity modulates multiple functions in microglia

  2009cited by this paper
• Tumor necrosis factor-alpha (TNF-α) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes

  2009cited by this paper
• Quantification of Myelin and Axon Pathology During Relapsing Progressive Experimental Autoimmune Encephalomyelitis in the Biozzi ABH Mouse

  2009cited by this paper
• The relation between inflammation and neurodegeneration in multiple sclerosis brains

  2009influential reference
• Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis.

  2009influential reference
• Characterization of acid‐sensing ion channel expression in oligodendrocyte‐lineage cells

  2008cited by this paper
• Amiloride is neuroprotective in an MPTP model of Parkinson's disease.

  2008cited by this paper
• Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases.

  2008cited by this paper
• Modulation of Acid-Sensing Ion Channel Activity by Nitric Oxide

  2007cited by this paper
• Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system

  2007cited by this paper
• T cells and microglia as drivers of multiple sclerosis pathology.

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

  2006cited by this paper
• Acid-sensing ion channel 1a is a postsynaptic proton receptor that affects the density of dendritic spines

  2006cited by this paper
• Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.

  2006cited by this paper
• NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia

  2006cited by this paper
• Sodium channels contribute to microglia/macrophage activation and function in EAE and MS

  2005cited by this paper
• Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?

  2005cited by this paper
• Na+-Dependent Sources of Intra-Axonal Ca2+ Release in Rat Optic Nerve during In Vitro Chemical Ischemia

  2005cited by this paper
• NMDA receptors are expressed in oligodendrocytes and activated in ischaemia

  2005cited by this paper
• Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.

  2004cited by this paper
• Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.

  2004cited by this paper
• Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger.

  2004cited by this paper
• Selective Regulation of Acid-sensing Ion Channel 1 by Serine Proteases*

  2004cited by this paper
• Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases

  2003cited by this paper
• Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release.

  2003cited by this paper
• Acid-Sensing Ion Channel 1 Is Localized in Brain Regions with High Synaptic Density and Contributes to Fear Conditioning

  2003cited by this paper
• Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration

  2003cited by this paper
• Temporal Course of Upregulation of Nav1.8 in Purkinje Neurons Parallels the Progression of Clinical Deficit in Experimental Allergic Encephalomyelitis

  2003cited by this paper
• cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity.

  2003cited by this paper
• A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions.

  2003cited by this paper
• Hypoxia-like tissue injury as a component of multiple sclerosis lesions

  2002cited by this paper
• The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory.

  2002influential reference
• GDNF and NGF reverse changes in repriming of TTX-sensitive Na(+) currents following axotomy of dorsal root ganglion neurons.

  2002cited by this paper
• Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

  2002influential reference
• ProInflammatory Mediators, Stimulators of Sensory Neuron Excitability via the Expression of Acid-Sensing Ion Channels

  2002cited by this paper
• The role of nitric oxide in multiple sclerosis.

  2002cited by this paper
• AMPA/Kainate Receptor Activation Mediates Hypoxic Oligodendrocyte Death and Axonal Injury in Cerebral White Matter

  2001cited by this paper
• Axonal L-type Ca2+ channels and anoxic injury in rat CNS white matter.

  2001cited by this paper
• Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.

  2000cited by this paper
• Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients

  2000cited by this paper
• Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.

  1999cited by this paper
• A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain.

  1999cited by this paper
• Apoptotic Cells Associated with Wallerian Degeneration After Experimental Spinal Cord Injury: A Possible Mechanism of Oligodendroglial Death

  1999cited by this paper
• Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis

  1999cited by this paper
• Axonal transection in the lesions of multiple sclerosis.

  1998cited by this paper
• AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS

  1998cited by this paper
• Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics

  1998cited by this paper
• The role of nitric oxide in multiple sclerosis

  1997cited by this paper
• A proton-gated cation channel involved in acid-sensing

  1997cited by this paper
• Myelination in the absence of myelin-associated glycoprotein

  1994cited by this paper
• Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques

  1993cited by this paper
• Noninactivating, tetrodotoxin-sensitive Na+ conductance in rat optic nerve axons.

  1993cited by this paper
• Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger

  1992cited by this paper
• Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid.

  1992cited by this paper
• Ion channels in spinal cord astrocytes in vitro. II. Biophysical and pharmacological analysis of two Na+ current types.

  1992cited by this paper
• Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

  1980cited by this paper

• Unveiling Acid-Sensing Ion Channels (ASICs) in Neurodegeneration: Implications for Disease Pathogenesis and Therapeutic Strategies

  2025cites this paper
• Astrocytic Acid-Sensing Ion Channel 1a Contributes to the Development of Epileptic Cognitive Impairment

  2025cites this paper
• Acid-sensing ion channels: structure, function, pharmacology and clinical significance.

  2025cites this paper
• Development of a Human Preclinical Platform for the Identification of Neuroprotective Compounds

  2025cites this paper
• 4-(Azolyl)-Benzamidines as a Novel Chemotype for ASIC1a Inhibitors

  2024cites this paper
• The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis

  2024cites this paper
• Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond

  2024cites this paper
• Opioid Analgesic as a Positive Allosteric Modulator of Acid-Sensing Ion Channels

  2024cites this paper
• Genetic or Pharmacological Ablation of Acid-Sensing Ion Channel 1a (ASIC1a) Is Not Neuroprotective in a Mouse Model of Spinal Cord Injury

  2023cites this paper
• Redistribution of ASIC1a channels triggered by IL-6: Potential role of ASIC1a in neuroinflammation.

  2023cites this paper
• Animal toxins: As an alternative therapeutic target following ischemic stroke condition.

  2023cites this paper
• Acute inhibition of acid sensing ion channel 1a after spinal cord injury selectively affects excitatory synaptic transmission, but not intrinsic membrane properties, in deep dorsal horn interneurons

  2023cites this paper
• Toward identifying key mechanisms of progression in multiple sclerosis.

  2023cites this paper
• Psalmotoxin-1 Venom on the Inflammatory Response and Burn Healing Process in the Experimental Burn Model

  2023cites this paper
• Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments

  2023influential citation
• Handbook of Ion Channels

  2023cites this paper
• A Phase 1 randomized study on the safety and pharmacokinetics of OCS-05, a neuroprotective disease modifying treatment for Acute Optic Neuritis and Multiple Sclerosis

  2023cites this paper
• Hydrogen Ion Dynamics as the Fundamental Link Between Neurodegenerative Diseases and Cancer. Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis in Multiple Sclerosis

  2022cites this paper
• Modulators of ASIC1a and its potential as a therapeutic target for age-related diseases.

  2022cites this paper
• Mechanisms of Action of the Peptide Toxins Targeting Human and Rodent Acid-Sensing Ion Channels and Relevance to Their In Vivo Analgesic Effects

  2022cites this paper
• Triggering of Major Brain Disorders by Protons and ATP: The Role of ASICs and P2X Receptors

  2022cites this paper
• The role of ion channels in immune-related diseases.

  2022cites this paper
• Interactive role of acid sensing ion channels and glutamatergic system in opioid dependence.

  2022cites this paper
• Acid-Sensing Ion Channel 2: Function and Modulation

  2022cites this paper
• Hydrogen Ion Dynamics as the Fundamental Link between Neurodegenerative Diseases and Cancer: Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis on Multiple Sclerosis

  2022cites this paper
• The Role of ASIC1a in Inflammatory Immune Diseases: A Potential Therapeutic Target

  2022cites this paper
• DEG/ENaC Ion Channels in the Function of the Nervous System: From Worm to Man.

  2021cites this paper
• Acid-Sensing Ion Channels and Mechanosensation

  2021cites this paper
• Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020

  2021cites this paper
• Progress in the Application of Drugs for the Treatment of Multiple Sclerosis

  2021cites this paper
• Commentary: Slowing of the Time Course of Acidification Decreases the Acid-Sensing Ion Channel 1a Current Amplitude and Modulates Action Potential Firing in Neurons

  2021cites this paper
• Acid-Sensing Ion Channels: Expression and Function in Resident and Infiltrating Immune Cells in the Central Nervous System

  2021cites this paper
• Neurodegenerative Disease: What Potential Therapeutic Role of Acid-Sensing Ion Channels?

  2021cites this paper
• The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: Behavioral and mechanistic study.

  2021cites this paper
• A flexible GAS belt responds to pore mutations changing the ion selectivity of proton-gated channels

  2021cites this paper
• Oligodendrocytes, BK channels and the preservation of myelin

  2021cites this paper
• Hydrogen Sulfide Upregulates Acid-sensing Ion Channels via the MAPK-Erk1/2 Signaling Pathway

  2021cites this paper
• Histamine and corticosterone modulate Acid sensing ion channels (ASICs) dependent long-term potentiation at the mouse anterior cingulate cortex.

  2021cites this paper
• Chemical modulation of Kv7 potassium channels.

  2021cites this paper
• A molecular view of the function and pharmacology of acid-sensing ion channels.

  2020cites this paper
• Neue Therapieansätze bei progredienter Multipler Sklerose

  2020cites this paper
• Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

  2020cites this paper
• Slowing of the Time Course of Acidification Decreases the Acid-Sensing Ion Channel 1a Current Amplitude and Modulates Action Potential Firing in Neurons

  2020cites this paper
• Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.

  2020cites this paper
• Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT

  2020cites this paper
• Association Between Severity of Diabetic Ketoacidosis at Diagnosis and Multiple Autoimmunity in Children With Type 1 Diabetes Mellitus: A Study From a Greek Tertiary Centre.

  2020cites this paper
• Are electrophysiological and oligodendrocyte alterations an element in the development of multiple sclerosis at the same time as or before the immune response?

  2020cites this paper
• Role of ASIC1a in Normal and Pathological Synaptic Plasticity.

  2020cites this paper
• Upregulation of acid sensing ion channel 1a (ASIC1a) by hydrogen peroxide through the JNK pathway

  2020cites this paper
• Commentary: Therapeutic Potential of Targeting the Auto-Inhibition of ASIC1a for Neuroprotection Against Ischemic Brain Injury

  2020cites this paper
• Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases

  2020cites this paper
• Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

  2019cites this paper
• Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial

  2019cites this paper
• Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation.

  2019cites this paper
• Basics on the use of acid-sensing ion channels’ inhibitors as therapeutics

  2019cites this paper
• Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis

  2019cites this paper
• Acid-Sensing Ion Channel 1a Is Involved in N-Methyl D-Aspartate Receptor-Dependent Long-Term Depression in the Hippocampus

  2019cites this paper
• Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview

  2018cites this paper
• The ion channel TRPM4 in murine experimental autoimmune encephalomyelitis and in a model of glutamate-induced neuronal degeneration

  2018cites this paper
• Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

  2018cites this paper
• Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis

  2018cites this paper
• Neue Therapieansätze bei progredienter Multipler Sklerose

  2018cites this paper
• Acid sensing ion channel 2: A new potential player in the pathophysiology of multiple sclerosis

  2018cites this paper
• Novel mechanism and biomarker of chronic progressive multiple sclerosis

  2018cites this paper
• Treatment of progressive multiple sclerosis: Challenges and promising perspectives.

  2018cites this paper
• Emerging drugs for primary progressive multiple sclerosis

  2018cites this paper
• Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes

  2018cites this paper
• Drug exposure and the risk of multiple sclerosis: A systematic review

  2018cites this paper
• Neuroprotective effects of inhibitors of Acid-Sensing ion channels (ASICs) in optic nerve crush model in rodents

  2018cites this paper
• Acid-sensing ion channels: dual function proteins for chemo-sensing and mechano-sensing

  2018cites this paper
• Mitochondrial function and dynamics in demyelinated axons

  2017cites this paper
• Progression of experimental autoimmune encephalomyelitis is associated with up‐regulation of major sodium transporters in the mouse kidney cortex under a normal salt diet

  2017cites this paper
• Acid-Sensing Ion Channels as Potential Therapeutic Targets in Neurodegeneration and Neuroinflammation

  2017cites this paper
• Cellular Localization of Acid-Sensing Ion Channel 1 in Rat Nucleus Tractus Solitarii

  2017cites this paper
• Protecting Oligodendrocytes by Targeting Non-Glutamate Receptors as a New Therapeutic Strategy for Ischemic Stroke

  2017cites this paper
• Nogo-A Antibodies for Progressive Multiple Sclerosis

  2017cites this paper
• Upcoming therapeutic options for progressive multiple sclerosis

  2017cites this paper
• Suppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels

  2017cites this paper
• Discovery and molecular interaction studies of a highly stable, tarantula peptide modulator of acid‐sensing ion channel 1

  2017cites this paper
• Novel Insights into Acid-Sensing Ion Channels: Implications for Degenerative Diseases.

  2016cites this paper
• Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future

  2016cites this paper
• Regulating Factors in Acid-Sensing Ion Channel 1a Function

  2016cites this paper
• Acid-Sensing Ion Channels as Potential Pharmacological Targets in Peripheral and Central Nervous System Diseases.

  2016cites this paper
• Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.

  2016cites this paper
• A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives

  2016cites this paper
• Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

  2016cites this paper
• Sodium MRI of multiple sclerosis

  2016cites this paper
• Progressive multiple sclerosis: from pathogenic mechanisms to treatment.

  2016cites this paper
• Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction

  2015cites this paper
• Down-sizing of neuronal network activity and density of presynaptic terminals by pathological acidosis are efficiently prevented by Diminazene Aceturate.

  2015cites this paper
• Cognitive Impairment in Multiple Sclerosis: Clinical, Radiologic and Pathologic Insights

  2015cites this paper
• Pharmacology of acid-sensing ion channels - Physiological and therapeutical perspectives.

  2015cites this paper
• Clinical Trial In Optic Neuritis ( ACTION ) protocol : a randomised , double blind , placebo controlled trial

  2015cites this paper
• Genetic exploration of the role of acid-sensing ion channels.

  2015cites this paper
• ASIC3 Mediates Itch Sensation in Response to Coincident Stimulation by Acid and Nonproton Ligand.

  2015cites this paper
• Smooth muscle acid‐sensing ion channel 1: pathophysiological implication in hypoxic pulmonary hypertension

  2015cites this paper
• Two aspects of ASIC function: Synaptic plasticity and neuronal injury.

  2015cites this paper
• Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis

  2015cites this paper
• Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis

  2015cites this paper
• The role of activated microglia in multiple sclerosis and clinically isolated syndromes : neuroimaging studies

  2015cites this paper